- Home
- DERM vs BACC Comparison
DERM vs BACC Comparison
Compare DERM & BACC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.95
Company Overview
Basic Information| Metric | DERM | BACC |
|---|---|---|
| Founded | 2014 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.4M | 284.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | DERM | BACC |
|---|---|---|
| Price | $4.95 | $10.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.67 | N/A |
| AVG Volume (30 Days) | ★ 271.8K | 61.5K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.72 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $61,858,000.00 | N/A |
| Revenue This Year | $66.12 | N/A |
| Revenue Next Year | $52.94 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $4.31 | $9.95 |
| 52 Week High | $9.56 | $10.44 |
Technical Indicators
Market Signals| Indicator | DERM | BACC |
|---|---|---|
| Relative Strength Index (RSI) | 28.45 | 61.40 |
| Support Level | N/A | $10.21 |
| Resistance Level | $8.05 | $10.27 |
| Average True Range (ATR) | 0.50 | 0.01 |
| MACD | -0.22 | 0.01 |
| Stochastic Oscillator | 17.39 | 100.00 |
Price Performance
Historical Comparison DERM
BACC
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About BACC Blue Acquisition Corp. Class A Ordinary Shares
Blue Acquisition Corp is a blank check company.